Testing the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model

Mathematically speaking, it is self-evident that the optimal control of complex, dynamical systems with many interacting components cannot be achieved with ‘non-responsive’ control strategies that are constant through time. Although there are notable exceptions, this is usually how we design treatme...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Royal Society interface Vol. 11; no. 96; p. 20131035
Main Authors Peña-Miller, Rafael, Fuentes-Hernandez, Ayari, Reding, Carlos, Gudelj, Ivana, Beardmore, Robert
Format Journal Article
LanguageEnglish
Published England The Royal Society 06.07.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mathematically speaking, it is self-evident that the optimal control of complex, dynamical systems with many interacting components cannot be achieved with ‘non-responsive’ control strategies that are constant through time. Although there are notable exceptions, this is usually how we design treatments with antimicrobial drugs when we give the same dose and the same antibiotic combination each day. Here, we use a frequency- and density-dependent pharmacogenetics mathematical model based on a standard, two-locus, two-allele representation of how bacteria resist antibiotics to probe the question of whether optimal antibiotic treatments might, in fact, be constant through time. The model describes the ecological and evolutionary dynamics of different sub-populations of the bacterium Escherichia coli that compete for a single limiting resource in a two-drug environment. We use in vitro evolutionary experiments to calibrate and test the model and show that antibiotic environments can support dynamically changing and heterogeneous population structures. We then demonstrate, theoretically and empirically, that the best treatment strategies should adapt through time and constant strategies are not optimal.
AbstractList Mathematically speaking, it is self-evident that the optimal control of complex, dynamical systems with many interacting components cannot be achieved with ‘non-responsive’ control strategies that are constant through time. Although there are notable exceptions, this is usually how we design treatments with antimicrobial drugs when we give the same dose and the same antibiotic combination each day. Here, we use a frequency- and density-dependent pharmacogenetics mathematical model based on a standard, two-locus, two-allele representation of how bacteria resist antibiotics to probe the question of whether optimal antibiotic treatments might, in fact, be constant through time. The model describes the ecological and evolutionary dynamics of different sub-populations of the bacterium Escherichia coli that compete for a single limiting resource in a two-drug environment. We use in vitro evolutionary experiments to calibrate and test the model and show that antibiotic environments can support dynamically changing and heterogeneous population structures. We then demonstrate, theoretically and empirically, that the best treatment strategies should adapt through time and constant strategies are not optimal.
Mathematically speaking, it is self-evident that the optimal control of complex, dynamical systems with many interacting components cannot be achieved with ‘non-responsive’ control strategies that are constant through time. Although there are notable exceptions, this is usually how we design treatments with antimicrobial drugs when we give the same dose and the same antibiotic combination each day. Here, we use a frequency- and density-dependent pharmacogenetics mathematical model based on a standard, two-locus, two-allele representation of how bacteria resist antibiotics to probe the question of whether optimal antibiotic treatments might, in fact, be constant through time. The model describes the ecological and evolutionary dynamics of different sub-populations of the bacterium Escherichia coli that compete for a single limiting resource in a two-drug environment. We use in vitro evolutionary experiments to calibrate and test the model and show that antibiotic environments can support dynamically changing and heterogeneous population structures. We then demonstrate, theoretically and empirically, that the best treatment strategies should adapt through time and constant strategies are not optimal.
Author Reding, Carlos
Beardmore, Robert
Gudelj, Ivana
Peña-Miller, Rafael
Fuentes-Hernandez, Ayari
AuthorAffiliation 1 Centro de Ciencias Genómicas , Universidad Nacional Autónoma de México , Cuernavaca, Morelos , México
2 Department of Biosciences , University of Exeter , Exeter EX4 4SB , UK
AuthorAffiliation_xml – name: 1 Centro de Ciencias Genómicas , Universidad Nacional Autónoma de México , Cuernavaca, Morelos , México
– name: 2 Department of Biosciences , University of Exeter , Exeter EX4 4SB , UK
Author_xml – sequence: 1
  givenname: Rafael
  surname: Peña-Miller
  fullname: Peña-Miller, Rafael
  organization: Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México
– sequence: 2
  givenname: Ayari
  surname: Fuentes-Hernandez
  fullname: Fuentes-Hernandez, Ayari
  organization: Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México
– sequence: 3
  givenname: Carlos
  surname: Reding
  fullname: Reding, Carlos
  organization: Department of Biosciences, University of Exeter, Exeter EX4 4SB, UK
– sequence: 4
  givenname: Ivana
  surname: Gudelj
  fullname: Gudelj, Ivana
  organization: Department of Biosciences, University of Exeter, Exeter EX4 4SB, UK
– sequence: 5
  givenname: Robert
  surname: Beardmore
  fullname: Beardmore, Robert
  email: r.e.beardmore@exeter.ac.uk
  organization: Department of Biosciences, University of Exeter, Exeter EX4 4SB, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24812050$$D View this record in MEDLINE/PubMed
BookMark eNp1kctv1DAQxi1URB9w5Yh85EAWP-LEuSBBxaNSK1S0wNHyOpPWxbFT2wH2v8fplhU9cPKM5pufZ-Y7Rgc-eEDoOSUrSjr5OiY7rBihvKRcPEJHtK1ZJZqGHexj2R2i45RuCOEtF-IJOmS1pIwIcoT0GlK2_grna8BhynbUzuYtnmKYIGYLCYcBa9zP2mHts93YkK3BOYLOI_iMrS_l_CtULpg5vboLtXPgAI-hB_cUPR60S_Ds_j1BXz-8X59-qs4_fzw7fXteGcFlrjradV3dlU2ACUlow_jGtLTnkui2r4eGkx5MwyU3bUMHSqQUlPeMDzUM0BJ-gt7suNO8GaE3ZbaonZpiWSluVdBWPax4e62uwk9VE84EEwXw8h4Qw-1czqJGmww4pz2EOSkqGK-JpM0iXe2kJoaUIgz7byhRiy9q8UUtvqjFl9Lw4t_h9vK_RhQB3wli2JYrBWMhb9VNmKMv6f-x1a7Lpgy_91Qdf6im5a1Q32StLr9_uVhfvhNK8j-gY6yM
CitedBy_id crossref_primary_10_1007_s12551_018_0404_9
crossref_primary_10_1371_journal_pone_0228240
crossref_primary_10_1214_23_EJP958
crossref_primary_10_1093_molbev_msab025
crossref_primary_10_1038_srep37853
crossref_primary_10_1038_ncomms15589
crossref_primary_10_1098_rsif_2019_0363
Cites_doi 10.1086/420937
10.1371/journal.pbio.1001540
10.1038/nchembio.2007.24
10.1093/jac/dks391
10.1126/science.321.5887.356
10.1111/j.1469-0691.2006.01454.x
10.1177/1756283X09343326
10.1093/jac/48.suppl_1.1
10.1111/j.1365-2036.2011.04843.x
10.1073/pnas.1100299108
10.1038/nchembio817
10.1126/science.1164586
10.1038/35012500
10.1086/605572
10.1016/S0140-6736(01)38705-6
10.1038/nrmicro2174
10.1371/journal.ppat.1003578
10.1371/journal.pone.0029838
10.1111/j.1432-1033.1981.tb06218.x
10.1038/nrmicro798
10.1128/AAC.26.2.220
10.1016/S1369-5274(99)00005-3
10.1073/pnas.0805965105
10.1126/science.1123539
10.2307/30141780
10.1084/jem.88.1.99
10.1128/CMR.18.4.638-656.2005
10.1098/rsif.2012.0279
10.1038/nrmicro2133
10.1086/595011
10.1093/jac/dkg301
10.1016/S1473-3099(01)00066-4
10.1128/AAC.05360-11
10.1097/CCM.0b013e318180fe62
10.1128/JCM.36.8.2169-2172.1998
10.1038/nm1145
10.1126/scitranslmed.3006055
10.1126/science.322.5903.853b
10.1093/jac/dki213
10.1016/S1473-3099(04)01145-4
10.1016/S0140-6736(11)60825-8
10.1016/j.jhin.2008.10.026
10.1007/s11538-011-9698-5
ContentType Journal Article
Copyright 2014 The Author(s) Published by the Royal Society. All rights reserved.
2014 The Author(s) Published by the Royal Society. All rights reserved. 2014
Copyright_xml – notice: 2014 The Author(s) Published by the Royal Society. All rights reserved.
– notice: 2014 The Author(s) Published by the Royal Society. All rights reserved. 2014
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1098/rsif.2013.1035
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Testing the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model
EISSN 1742-5662
EndPage 20131035
ExternalDocumentID 10_1098_rsif_2013_1035
24812050
ark_67375_V84_QWRMTQB5_8
Genre Journal Article
GroupedDBID ---
0R~
18M
29L
2WC
4.4
53G
5GY
5VS
ACGFO
ACQIA
ADBBV
ADDVE
AENEX
AJZGM
ALMA_UNASSIGNED_HOLDINGS
ALMYZ
AOIJS
BAWUL
BGBPD
BSCLL
BTFSW
CS3
DIK
DU5
EBS
EJD
GX1
H13
HH5
HYE
HZ~
KQ8
MRS
MV1
NSAHA
O9-
OK1
OP1
P2P
RHF
RPM
RRY
TR2
V1E
W8F
XSW
ABXXB
ICLEN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c538t-9199949013e25801623bc71d380a7d4f630dec6383c761f1088513d23f4efe703
IEDL.DBID RPM
ISSN 1742-5689
IngestDate Tue Sep 17 21:33:45 EDT 2024
Sat Oct 05 04:38:09 EDT 2024
Thu Sep 26 15:24:41 EDT 2024
Sat Sep 28 08:31:49 EDT 2024
Wed Jan 17 02:36:54 EST 2024
Wed Oct 30 09:38:13 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 96
Keywords antibiotic resistance evolution
population genetics
multidrug combinations
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c538t-9199949013e25801623bc71d380a7d4f630dec6383c761f1088513d23f4efe703
Notes ArticleID:rsif20131035
istex:D382ADCB113384B8A8B4988BBD21719AD48AA952
ark:/67375/V84-QWRMTQB5-8
href:rsif20131035.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://royalsocietypublishing.org/doi/pdf/10.1098/rsif.2013.1035
PMID 24812050
PQID 1523408165
PQPubID 23479
PageCount 1
ParticipantIDs istex_primary_ark_67375_V84_QWRMTQB5_8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4032525
royalsociety_journals_10_1098_rsif_2013_1035
crossref_primary_10_1098_rsif_2013_1035
proquest_miscellaneous_1523408165
pubmed_primary_24812050
PublicationCentury 2000
PublicationDate 2014-07-06
20140706
2014-Jul-06
PublicationDateYYYYMMDD 2014-07-06
PublicationDate_xml – month: 07
  year: 2014
  text: 2014-07-06
  day: 06
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of the Royal Society interface
PublicationTitleAbbrev J. R. Soc. Interface
PublicationTitleAlternate J. R. Soc. Interface
PublicationYear 2014
Publisher The Royal Society
Publisher_xml – name: The Royal Society
References e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_28_2
e_1_3_2_29_2
Greco WR (e_1_3_2_23_2) 1995; 47
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
Pugh R (e_1_3_2_11_2) 2011
e_1_3_2_21_2
Amsterdam D (e_1_3_2_31_2) 2005
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_46_2
Bergeron M (e_1_3_2_47_2) 1998; 36
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_5_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
References_xml – ident: e_1_3_2_8_2
  doi: 10.1086/420937
– start-page: CD007577
  year: 2011
  ident: e_1_3_2_11_2
  article-title: Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
  publication-title: .
  contributor:
    fullname: Pugh R
– ident: e_1_3_2_25_2
  doi: 10.1371/journal.pbio.1001540
– ident: e_1_3_2_43_2
– ident: e_1_3_2_4_2
  doi: 10.1038/nchembio.2007.24
– ident: e_1_3_2_30_2
  doi: 10.1093/jac/dks391
– ident: e_1_3_2_14_2
  doi: 10.1126/science.321.5887.356
– ident: e_1_3_2_40_2
  doi: 10.1111/j.1469-0691.2006.01454.x
– ident: e_1_3_2_45_2
  doi: 10.1177/1756283X09343326
– ident: e_1_3_2_39_2
  doi: 10.1093/jac/48.suppl_1.1
– ident: e_1_3_2_44_2
  doi: 10.1111/j.1365-2036.2011.04843.x
– ident: e_1_3_2_24_2
  doi: 10.1073/pnas.1100299108
– ident: e_1_3_2_22_2
  doi: 10.1038/nchembio817
– start-page: 61
  volume-title: Antibiotics in laboratory medicine
  year: 2005
  ident: e_1_3_2_31_2
  contributor:
    fullname: Amsterdam D
– ident: e_1_3_2_7_2
  doi: 10.1126/science.1164586
– ident: e_1_3_2_36_2
  doi: 10.1038/35012500
– ident: e_1_3_2_28_2
  doi: 10.1086/605572
– volume: 47
  start-page: 331
  year: 1995
  ident: e_1_3_2_23_2
  article-title: The search for synergy: a critical review from a response surface perspective
  publication-title: Pharmacol. Rev.
  contributor:
    fullname: Greco WR
– ident: e_1_3_2_18_2
  doi: 10.1016/S0140-6736(01)38705-6
– ident: e_1_3_2_38_2
  doi: 10.1038/nrmicro2174
– ident: e_1_3_2_17_2
  doi: 10.1371/journal.ppat.1003578
– ident: e_1_3_2_13_2
  doi: 10.1371/journal.pone.0029838
– ident: e_1_3_2_34_2
  doi: 10.1111/j.1432-1033.1981.tb06218.x
– ident: e_1_3_2_6_2
  doi: 10.1038/nrmicro798
– ident: e_1_3_2_29_2
  doi: 10.1128/AAC.26.2.220
– ident: e_1_3_2_35_2
  doi: 10.1016/S1369-5274(99)00005-3
– ident: e_1_3_2_26_2
  doi: 10.1073/pnas.0805965105
– ident: e_1_3_2_37_2
  doi: 10.1126/science.1123539
– ident: e_1_3_2_48_2
  doi: 10.2307/30141780
– ident: e_1_3_2_41_2
  doi: 10.1084/jem.88.1.99
– ident: e_1_3_2_49_2
  doi: 10.1128/CMR.18.4.638-656.2005
– ident: e_1_3_2_33_2
  doi: 10.1098/rsif.2012.0279
– ident: e_1_3_2_27_2
  doi: 10.1038/nrmicro2133
– ident: e_1_3_2_3_2
  doi: 10.1086/595011
– ident: e_1_3_2_42_2
  doi: 10.1093/jac/dkg301
– ident: e_1_3_2_21_2
  doi: 10.1016/S1473-3099(01)00066-4
– ident: e_1_3_2_12_2
  doi: 10.1128/AAC.05360-11
– ident: e_1_3_2_10_2
  doi: 10.1097/CCM.0b013e318180fe62
– volume: 36
  start-page: 2169
  year: 1998
  ident: e_1_3_2_47_2
  article-title: Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory
  publication-title: Clin. Microbiol.
  doi: 10.1128/JCM.36.8.2169-2172.1998
  contributor:
    fullname: Bergeron M
– ident: e_1_3_2_2_2
  doi: 10.1038/nm1145
– ident: e_1_3_2_20_2
  doi: 10.1126/scitranslmed.3006055
– ident: e_1_3_2_15_2
  doi: 10.1126/science.322.5903.853b
– ident: e_1_3_2_9_2
  doi: 10.1093/jac/dki213
– ident: e_1_3_2_19_2
  doi: 10.1016/S1473-3099(04)01145-4
– ident: e_1_3_2_46_2
  doi: 10.1016/S0140-6736(11)60825-8
– ident: e_1_3_2_5_2
  doi: 10.1016/j.jhin.2008.10.026
– ident: e_1_3_2_16_2
  doi: 10.1126/science.322.5903.853b
– ident: e_1_3_2_32_2
  doi: 10.1007/s11538-011-9698-5
SSID ssj0037355
Score 2.1689804
Snippet Mathematically speaking, it is self-evident that the optimal control of complex, dynamical systems with many interacting components cannot be achieved with...
SourceID pubmedcentral
proquest
crossref
pubmed
royalsociety
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 20131035
SubjectTerms Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - pharmacology
Antibiotic Resistance Evolution
Drug Resistance, Bacterial - genetics
Escherichia coli - drug effects
Escherichia coli - genetics
Evolution, Molecular
Microbial Sensitivity Tests - methods
Models, Theoretical
Multidrug Combinations
Population Genetics
Title Testing the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model
URI https://api.istex.fr/ark:/67375/V84-QWRMTQB5-8/fulltext.pdf
https://royalsocietypublishing.org/doi/full/10.1098/rsif.2013.1035
https://www.ncbi.nlm.nih.gov/pubmed/24812050
https://search.proquest.com/docview/1523408165
https://pubmed.ncbi.nlm.nih.gov/PMC4032525
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB615cIFUZ7hJSMhHlLTzcZ2nD1CRVUhLaJoC71ZjmNDRDdZbXYFP58Z56GtVC7cItlyEn_2zDf2PABeJTI1UhoRW-tLNFCUi4tc-lgZ7mya-EwKChSef87OLsSnS3m5B3KIhQlO-7aojuur5XFd_Qy-laulnQx-YpMv8xOR8FSmcrIP-7hABxO9E79c8VDqFJk2WllZPhszNeYTNL9D1k5OoeZUsyYVqN8SirnfUUq3aH7_3MQ4b3CcXJOR33YOljuK6fQu3OkZJXvfffkh7Ln6Hhz2e7Zlb_vE0u_ug1lQSo36B0PSxxqUFctAwtmKDuTXlFmVNZ4ZRuFZDGe8KqoGB2WjMzqramze_G5iVIHb9ig8UjGWK8dCSZ0HcHH6cXFyFvclFmKLkm6Dog4JopjRWWgqUVkhGSqsmpY8T4wqhc94UjqLe5RblU39FGWSnPIy5V4471BaPISDuqndY2BeItfCaeXc5GgF5YVPrVfIfxxSkMLNIngzzLFedZk0dHcDnmsCRhMwmoCJ4HWAYOxm1r_I_0xJ_S0X-vz71_ni_IPUeQQvB4w07gq66jC1a7atRlbCBdUUwcEedZiNow2gR6CuoTl2oIzb11twIYbM2_3Ci-BoF3fdb_v2H__z5L9f9BRu4ygiuAdnz-Bgs96650iCNsWLsOj_AojKBdI
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6V9gAXRHnVLdBFQjykunG8u7ZzpBVVgKaiKIXeVvZ6l1pt7ChOBD-fmfVDqVQu3CzZWtvzeWa-Wc8D4E0gw1TKVPha2xwDlNj4WSKtH6fc6DCwkRRUKDw5i8YX4sulvNwA2dXCuKR9nRWH5c3ssCyuXG7lfKYHXZ7Y4NvkWAQ8lKEc3IMt1NdAdEF6Y4B5zN2wU-TaGGdFyajv1ZgMMAB3fTs5FZvT1JpQoIcLqOp-zS1tkYT_3MU570idXFCYXzcplmuu6eQRPGw5JfvYPPs2bJjyMWy3Wluz921r6Q9PIJ1SU43yF0Paxyq0FjNHw9mctuQX1FuVVZaljAq0GMq8yIoKF2V9OjorSjy9_F356ARX9YE7pHEsN4a5oTpP4eLk0_R47LdDFnyNsluisUOKKEa0GxpKdFdIhzIdD3OUaxrnwkY8yI1GLeU6joZ2iFZJDnkeciuMNWgvnsFmWZVmB5iVyLZQrJynCcZBSWZDbWNkQAZJSGZGHrzrZKzmTS8N1fwDTxQBowgYRcB48NZB0F-WLq4pAy2W6kci1PnP75Pp-ZFUiQevO4wU6gX97EhLU61qhbyEC5oqgos9bzDrV-tA9yC-hWZ_AfXcvn0GP0XXe7v99Dw4WMddtYpf_-N9dv_7RvtwfzydnKrTz2df9-ABrihcsnD0AjaXi5V5iZRomb1yCvAXdUoJKA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELaglRAviHKmXEZCHFLTZGM7zj5CYVWOrVq0pX2zHMeGqN1ktdkV_HxmnENbqbzwFsmWk8znmfkmGc8Q8ioWiRZC89AYV0CAIm2YZ8KFUjNrktilguNB4elRenjKv5yL841WXz5p3-TlfnU536_KXz63cjE3UZ8nFh1PD3jMEpGIaFG46CbZBp2N0z5Qb40wk8w3PAW-DbFWmo2Heo1ZBEG4r93J8MA5dq5JOHi5GE_eb7imbZTyn-t45zXpk0sM9Zs2zXLDPU3ukjsdr6Tv2-ffITdsdY_sdJrb0Lddeel394meYWGN6icF6kdrsBhzT8XpAj_LL7G-Kq0d1RQPaVGQe5mXNSxKh5R0WlYwvPpdh-AI182ev8SWLJeW-sY6D8jp5NPs4DDsGi2EBmS3AoMHNJGP8YtoIsBlASXKjRwVIFctC-5SFhfWgKYyI9ORG4FlEiNWJMxx6yzYjIdkq6or-5hQJ4BxgVgZ0xnEQlnuEuMksCALRCS344C86WWsFm09DdX-B88UAqMQGIXABOS1h2CYppcXmIUmhfqRcXVy9n06O_kgVBaQlz1GCnQDf3joytbrRgE3YRw7i8Bij1rMhtV60AMir6A5TMC621dHYDv6-tvd9gvI3ibuqlP-5h_vs_vfN3pBbh1_nKhvn4--PiG3YUHu84XTp2RrtVzbZ8CKVvlzv___AkiwCjs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Testing+the+optimality+properties+of+a+dual+antibiotic+treatment+in+a+two-locus%2C+two-allele+model&rft.jtitle=Journal+of+the+Royal+Society+interface&rft.au=Pe%C3%B1a-Miller%2C+Rafael&rft.au=Fuentes-Hernandez%2C+Ayari&rft.au=Reding%2C+Carlos&rft.au=Gudelj%2C+Ivana&rft.date=2014-07-06&rft.pub=The+Royal+Society&rft.issn=1742-5689&rft.eissn=1742-5662&rft.volume=11&rft.issue=96&rft_id=info:doi/10.1098%2Frsif.2013.1035&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_V84_QWRMTQB5_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-5689&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-5689&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-5689&client=summon